Table 3.
Cyclooxygenase-independent direct cellular targets of NSAIDs and metabolites.
| Sulindac | Sulindac sulfide | Sulindac sulfone | Celecoxib | Valdecoxib | Aspirin | Salicylate | Indomethacin | R-etodolac | Reference | |
|---|---|---|---|---|---|---|---|---|---|---|
| COX | ||||||||||
| COX-1 | – | ✓ | – | – | – | ✓ | – | ✓ | – | |
| COX-2 | – | ✓ | – | ✓ | ✓ | ✓ | – | ✓ | – | |
| COX-INDEPENDENT TARGETS | ||||||||||
| PDE5 | ✓ | ✓ | ✓ | Thompson et al. (71), Tinsley et al. (61), Tinsley et al. (72), Klein et al. (75) | ||||||
| PPARγ | ✓ | Lehmann et al. (88) | ||||||||
| PPARδ | ✓ | ✓ | He et al. (92) | |||||||
| RXRα | ✓ | ✓ | Kolluri et al. (98), Zhou et al. (100) | |||||||
| IKKβ | ✓ | ✓ | ✓ | Yamamoto et al. (104), Yin et al. (106) | ||||||
| PDK-1 | ✓ | Zhu et al. (111), Arico et al. (112), Kulp et al. (113) | ||||||||
| SERCA | ✓ | ✓ | Johnson et al. (117), White et al. (123) | |||||||
| CA IX/XII | ✓ | ✓ | Weber et al. (128), Di Fiore et al. (129) | |||||||
| Sp1 | ✓ | Wei et al. (157) | ||||||||
| AMPK | ✓ | Hawley et al. (168) | ||||||||